EPO Patent EP3727468A1: AAV-mediated delivery of therapeutic antibodies to inner ear

ChangeBridge: EPO Bulletin - Peptides (C07K)

Published March 11th, 2026

Detected March 25th, 2026

Summary

The European Patent Office has published patent application EP3727468A1 concerning AAV-mediated delivery of therapeutic antibodies to the inner ear. The patent is assigned to Akouos, Inc. and lists Emmanuel J. Simons, Robert Ng, and Michael McKenna as inventors.

View original document View source feed page

What changed

This document is a publication of a European patent application (EP3727468A1) by Akouos, Inc., detailing a method for AAV-mediated delivery of therapeutic antibodies to the inner ear. The patent covers specific inventions related to gene therapy for inner ear conditions.

As this is a patent publication, there are no immediate compliance obligations or deadlines for regulated entities. However, companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in gene therapy or treatments for inner ear disorders, should be aware of this intellectual property filing. It may impact future research, development, and commercialization strategies.

Source document (simplified)

← EPO Patent Bulletin

AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR

Publication EP3727468A1 Kind: A1 Mar 11, 2026

Applicants

Akouos, Inc.

Inventors

SIMONS, Emmanuel J., NG, Robert, MCKENNA, Michael

IPC Classifications

A61K 48/00 20060101AFI20210819BHEP A61K 9/00 20060101ALI20210819BHEP A61K 39/395 20060101ALI20210819BHEP A61P 27/16 20060101ALI20210819BHEP C07K 16/22 20060101ALI20210819BHEP C12N 15/113 20100101ALI20210819BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →